178 related articles for article (PubMed ID: 32973513)
1. Development of Anthraquinone Derivatives as Ectonucleoside Triphosphate Diphosphohydrolase (NTPDase) Inhibitors With Selectivity for NTPDase2 and NTPDase3.
Baqi Y; Rashed M; Schäkel L; Malik EM; Pelletier J; Sévigny J; Fiene A; Müller CE
Front Pharmacol; 2020; 11():1282. PubMed ID: 32973513
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of anthraquinone derivatives derived from bromaminic acid as inhibitors of ectonucleoside triphosphate diphosphohydrolases (E-NTPDases).
Baqi Y; Weyler S; Iqbal J; Zimmermann H; Müller CE
Purinergic Signal; 2009 Mar; 5(1):91-106. PubMed ID: 18528783
[TBL] [Abstract][Full Text] [Related]
3. Highly Potent and Selective Ectonucleoside Triphosphate Diphosphohydrolase (ENTPDase1, 2, 3 and 8) Inhibitors Having 2-substituted-7- trifluoromethyl-thiadiazolopyrimidones Scaffold.
Afzal S; Zaib S; Jafari B; Langer P; Lecka J; Sévigny J; Iqbal J
Med Chem; 2020; 16(5):689-702. PubMed ID: 31203806
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, In-vitro evaluation and molecular docking studies of oxoindolin phenylhydrazine carboxamides as potent and selective inhibitors of ectonucleoside triphosphate diphosphohydrolase (NTPDase).
Afzal S; Al-Rashida M; Hameed A; Pelletier J; Sévigny J; Iqbal J
Bioorg Chem; 2021 Jul; 112():104957. PubMed ID: 34020240
[TBL] [Abstract][Full Text] [Related]
5. Functionalized Oxoindolin Hydrazine Carbothioamide Derivatives as Highly Potent Inhibitors of Nucleoside Triphosphate Diphosphohydrolases.
Afzal S; Al-Rashida M; Hameed A; Pelletier J; Sévigny J; Iqbal J
Front Pharmacol; 2020; 11():585876. PubMed ID: 33328992
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors for the bacterial ectonucleotidase Lp1NTPDase from Legionella pneumophila.
Fiene A; Baqi Y; Malik EM; Newton P; Li W; Lee SY; Hartland EL; Müller CE
Bioorg Med Chem; 2016 Sep; 24(18):4363-4371. PubMed ID: 27522579
[TBL] [Abstract][Full Text] [Related]
7. Development of potent and selective inhibitors of ecto-5'-nucleotidase based on an anthraquinone scaffold.
Baqi Y; Lee SY; Iqbal J; Ripphausen P; Lehr A; Scheiff AB; Zimmermann H; Bajorath J; Müller CE
J Med Chem; 2010 Mar; 53(5):2076-86. PubMed ID: 20146483
[TBL] [Abstract][Full Text] [Related]
8. Selective nucleoside triphosphate diphosphohydrolase-2 (NTPDase2) inhibitors: nucleotide mimetics derived from uridine-5'-carboxamide.
Brunschweiger A; Iqbal J; Umbach F; Scheiff AB; Munkonda MN; Sévigny J; Knowles AF; Müller CE
J Med Chem; 2008 Aug; 51(15):4518-28. PubMed ID: 18630897
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of NTPDase2 in complex with the sulfoanthraquinone inhibitor PSB-071.
Zebisch M; Baqi Y; Schäfer P; Müller CE; Sträter N
J Struct Biol; 2014 Mar; 185(3):336-41. PubMed ID: 24462745
[TBL] [Abstract][Full Text] [Related]
10. Divergent synthesis and elaboration of structure activity relationship for quinoline derivatives as highly selective NTPDase inhibitor.
Murtaza A; Afzal S; Zaman G; Saeed A; Pelletier J; Sévigny J; Iqbal J; Hassan A
Bioorg Chem; 2021 Oct; 115():105240. PubMed ID: 34416508
[TBL] [Abstract][Full Text] [Related]
11. Discovery of potent competitive antagonists and positive modulators of the P2X2 receptor.
Baqi Y; Hausmann R; Rosefort C; Rettinger J; Schmalzing G; Müller CE
J Med Chem; 2011 Feb; 54(3):817-30. PubMed ID: 21207957
[TBL] [Abstract][Full Text] [Related]
12. High-affinity, non-nucleotide-derived competitive antagonists of platelet P2Y12 receptors.
Baqi Y; Atzler K; Köse M; Glänzel M; Müller CE
J Med Chem; 2009 Jun; 52(12):3784-93. PubMed ID: 19463000
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence polarization immunoassays for monitoring nucleoside triphosphate diphosphohydrolase (NTPDase) activity.
Fiene A; Baqi Y; Lecka J; Sévigny J; Müller CE
Analyst; 2015 Jan; 140(1):140-8. PubMed ID: 25372046
[TBL] [Abstract][Full Text] [Related]
14. The structure of the nucleoside triphosphate diphosphohydrolases (NTPDases) as revealed by mutagenic and computational modeling analyses.
Kirley TL; Crawford PA; Smith TM
Purinergic Signal; 2006 Jun; 2(2):379-89. PubMed ID: 17710224
[TBL] [Abstract][Full Text] [Related]
15. Trichomonas vaginalis NTPDase and ecto-5'-nucleotidase hydrolyze guanine nucleotides and increase extracellular guanosine levels under serum restriction.
Menezes CB; Durgante J; de Oliveira RR; Dos Santos VH; Rodrigues LF; Garcia SC; Dos Santos O; Tasca T
Mol Biochem Parasitol; 2016 May; 207(1):10-8. PubMed ID: 27150347
[TBL] [Abstract][Full Text] [Related]
16. Ectonucleotidases in the digestive system: focus on NTPDase3 localization.
Lavoie EG; Gulbransen BD; Martín-Satué M; Aliagas E; Sharkey KA; Sévigny J
Am J Physiol Gastrointest Liver Physiol; 2011 Apr; 300(4):G608-20. PubMed ID: 21233276
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization and biological evaluation of thiadiazole amide derivatives as nucleoside triphosphate diphosphohydrolases (NTPDases) inhibitors.
Abbas S; Afzal S; Nadeem H; Hussain D; Langer P; Sévigny J; Ashraf Z; Iqbal J
Bioorg Chem; 2022 Jan; 118():105456. PubMed ID: 34800887
[TBL] [Abstract][Full Text] [Related]
18. Various N-glycoforms differentially upregulate E-NTPDase activity of the NTPDase3/CD39L3 ecto-enzymatic domain.
Zhong AH; Gordon Jiang Z; Cummings RD; Robson SC
Purinergic Signal; 2017 Dec; 13(4):601-609. PubMed ID: 28956227
[TBL] [Abstract][Full Text] [Related]
19. Cloning and characterization of the ecto-nucleotidase NTPDase3 from rat brain: Predicted secondary structure and relation to other members of the E-NTPDase family and actin.
Vorhoff T; Zimmermann H; Pelletier J; Sévigny J; Braun N
Purinergic Signal; 2005 Sep; 1(3):259-70. PubMed ID: 18404510
[TBL] [Abstract][Full Text] [Related]
20. Development of Potent and Selective Antagonists for the UTP-Activated P2Y
Rafehi M; Malik EM; Neumann A; Abdelrahman A; Hanck T; Namasivayam V; Müller CE; Baqi Y
J Med Chem; 2017 Apr; 60(7):3020-3038. PubMed ID: 28306255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
